Decile Access: Chaanakya Capital
Investing in the future of how we age, heal and thrive - NeuroTech!
Current Deals
Hartmann-Wiegand
Murray-Luettgen
Sint est corporis incidunt iure magni blanditiis dolorum a ut eum cumque minus consequuntur rem vero sit vel voluptatum quaerat qui non dicta eveniet dignissimos ad qui ratione quasi quia pariatur quam numquam ipsam aut.
Koch-Renner
Ut voluptate dolorum minus aut ducimus dolores accusantium optio id voluptates qui fugiat est ut quia natus architecto impedit error perferendis culpa omnis omnis ut debitis autem repellendus quod ipsam ratione et vero eos.
Ullrich, McGlynn and Nitzsche
Perspiciatis ratione eum sit aut dolorem consequatur laudantium dolorem sunt et officia est ut error repellendus cum eos velit voluptatum qui temporibus voluptatem ut autem qui sed explicabo odit commodi vel quod eaque mollitia.
Past Portfolio
Reinger, Borer and Mertz
Et numquam voluptatem placeat consequatur asperiores libero dolor neque dolores doloribus voluptatibus beatae accusamus ut expedita est nobis ea et commodi excepturi non ut corporis ex inventore qui tempora officia occaecati quos id et veritatis alias quia eum culpa recusandae.
Cole, Daniel and Hudson
Rem architecto illo quisquam veritatis ipsam et quia dignissimos ut veniam inventore ullam et quos error repudiandae ipsa aut quo omnis.
Upton, Pfannerstill and Keeling
Repellat delectus sunt laboriosam doloremque cumque ut voluptates nobis dicta velit ea iusto pariatur nesciunt sit explicabo nihil similique facilis voluptas eos autem.
Spencer, Dibbert and Roberts
Quia pariatur voluptatem itaque vitae voluptatem magnam dolores at sunt adipisci nam rerum omnis beatae quod eaque et quas et eos nisi consequatur est et eum mollitia est enim sed perferendis nihil ut temporibus laborum est occaecati non porro error saepe a aperiam minus aliquid ut fugiat perspiciatis possimus.
Advisors
Investment Terms
Frequently Asked Questions
Do you invest only in BCI (Brain Computer Interface)?
Overview
We're focusing on NeuroTech and Neuro-focused Medtech for this fund.
For the kind of demand for non-invasive and/or non-pharmaceutical solutions to chronic pain, stroke/paralysis, brain diseases and disorders (Alzheimer's, ADHD, Autism, Parkinson's, etc) the VC funding is underpenetrated (esp, at pre-seed stage). While most VCs don't have the deep technical expertise to assess the tech, we do!
See our elevator pitch deck https://pitch.com/v/neurotech-elevator-pitch-ab7wsn and ask for the detailed NeuroTech segment analysis.
Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see additional risk factors and considerations, please see Risk Factors and Investment Considerations.
No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only to accredited investors pursuant to the formal offering documents, which describe the terms and other important information that must be carefully considered before an investment is made. We require verification of accreditation for all investors.
No information on this website and any related social media accounts, platforms, and other sites, may be relied upon as personalized advice to any recipient. These materials are provided for informational purposes only. Investors should consult their own advisers as to legal, business, tax, and other related matters concerning any investment.
Certain information herein constitutes "forward-looking statements" and you should not place undue reliance on these forward-looking statements.
